Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

India · Delayed Price · Currency is INR

215.00

+0.65 (0.30%)

Mar 5, 2026, 3:03 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Sale of Product Activity	561.16M	632.19M	597.92M	446.39M	350.18M
Sale of Product Activity Growth	-11.24%	5.73%	33.94%	27.48%	-
Unallocable	77.95M	123.90M	195.00M	143.72M	72.81M
Unallocable Growth	-37.08%	-36.46%	35.68%	97.39%	-
Hospital Activity	231.99M	217.38M	198.77M	156.95M	99.76M
Hospital Activity Growth	6.72%	9.36%	26.64%	57.32%	-
Total	871.10M	973.47M	991.69M	747.07M	522.75M
Total Growth	-10.52%	-1.84%	32.74%	42.91%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
India	898.47M	993.31M	991.69M	747.11M	522.75M
India Growth	-9.55%	0.16%	32.74%	42.92%	-30.51%
Total	898.47M	993.31M	991.69M	747.11M	522.75M
Total Growth	-9.55%	0.16%	32.74%	42.92%	-30.51%

Source: S&P Global Market Intelligence.